Direxion Daily Healthcare Bull 3X Shares CURE
166.60 USD -14.02 (-7.76%)
At closeNov 5, 2026, 4:07 PM EST
165.50 -1.10 -0.66%
After hours · Nov 5, 4:07 PM ET
166.44 Day range 187.79
82.41 52-week range 187.79
- YTD
- +49.34%
- 1 year
- +76.60%
- Market cap
- 216.75M
- EPS (ttm)
- 5.10
- P/E ratio
- 32.67
- YTD return
- +49.34%
- 1-year return
- +76.60%
- Volume
- 176.93K
- Avg volume
- 56.56K
- Open
- 185.07
- Previous close
- 180.62
- Day's range
- 166.44 – 187.79
- 52-week range
- 82.41 – 187.79
5m +0.75 (+0.45%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 112.30
- 200-day average
- 119.09
About Direxion Daily Healthcare Bull 3X Shares
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
News
Top Performing Leveraged/Inverse ETFs: 10/25/2026 
Biocure Technology Inc. enters into exclusive Letter Agreement to acquire Glorious Success Limited in Reverse Takeover Transaction 
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity 
Which Sector Topped the Leaderboard for January Returns? 
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks 
CURE: Analysts Strike A Cautious Tone Heading Into 2026 
Direxion's 5 Single-Stock ETFs, Including Coinbase and Robinhood 
Top Performing Leveraged/Inverse ETFs: 11/16/2025 
These Stocks Could Be Catalysts for CURE 
Follow Signals, Don't Chase Price - JD Henning
Your note
Sign in to keep a note on CURE — it syncs with the Stock Master app.